Vensana Capital Strengthens Team with Two MedTech Veterans

Vensana Capital, a prominent medical technology-focused venture capital and growth equity investment firm, has announced the addition of two seasoned professionals to its team. Maria Berkman, MD, joins as a Partner, bringing over a decade of experience from Broadview Ventures, where she played a pivotal role in the firm's growth and invested in nearly 20 medical technology companies. Ross (Rusty) Segan, MD, comes on board as a Venture Partner, offering over 25 years of global experience in the medtech industry, including leadership roles at the FDA and major medical device companies. These strategic hires underscore Vensana's commitment to building a team with deep expertise in the medtech sector to foster the next generation of innovative healthcare solutions.

The firm, which has approximately $1 billion in capital under management, focuses on transformative innovations in medical technology, including medical devices, data science-oriented solutions, and tech-enabled services. The appointments of Berkman and Segan are expected to enhance Vensana's ability to identify and support groundbreaking medtech companies, further solidifying its position as a leader in the industry. For more details, visit www.vensanacap.com.